帕金森病（Parkinson disease，PD）是神经系统常见变性疾病，主要表现为运动迟缓、静止性震颤及肌强直，治疗药物主要包括左旋多巴复合制剂、多巴胺受体激动剂、抗胆碱能药、单胺氧化酶B型抑制剂、儿茶酚-O-甲基转移酶抑制剂等[1]。重症肌无力 ...

antibodies. Specialized tests use electricity to stimulate muscles and measure the strength of muscle contraction. If you have myasthenia gravis, muscle strength will decrease predictably over the ...

had clinically meaningful efficacy and a favorable safety profile among people with generalized myasthenia gravis (gMG), ...

Myasthenia gravis (MG) should be subgrouped into early-onset, late-onset, thymoma, ocular, anti-MuSK, anti-LRP4 and antibody-negative MG. MG has a prevalence of 140 per million, and an annual ...

Myasthenia Gravis is a long-term, autoimmune condition in which the communication between muscles and nerves is impaired due to the production of certain antibodies resulting in voluntary muscle ...

In myasthenia gravis, the receptors for acetylcholine at the muscle surface are destroyed or modulated by antibodies that prevent the normal reaction from occurring. The antibodies are produced by the ...

MEDLINE 5. Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A: Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against ...

MEDLINE 5. Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A: Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against ...

Myasthenia gravis treatment aims to minimize the effects of muscle weakness due to an immune process. It includes medications ...